Clinical Trial Update: Comparative Effectiveness of Dapagliflozin, Metformin, and Lifestyle Modification for Antipsychotic-Induced Weight Gain: An Open-Label Pragmatic Trial [Phase 4]

View source ↗

Summary

Phase 4 open-label pragmatic trial comparing dapagliflozin, metformin, and lifestyle modification for antipsychotic-induced weight gain; status NOT_YET_RECRUITI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antipsychotic-induced Weight Gain
• Schizophrenia Spectrum and Other Psychotic Disorders

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• metformin (metformin)

Snippet

Sponsor: Sultan Qaboos University | Conditions: Antipsychotic-induced Weight Gain (AIWG), Antipsychotic-induced Weight Gain | Phase 4 | Status: NOT_YET_RECRUITING